ClinicalTrials.govpublic full text
Immune Checkpoint Inhibitors and Anti-vascular Endothelial Growth Factor Antibody/Tyrosine Kinase Inhibitors With or Without HAIC for Unresectable HCC With Portal Vein Tumor Thrombosis
hepatocellular carcinoma (hcc), hepatocellular carcinoma, immune checkpoint inhibitors, molecular target therapies, hepatic infusion chemotherapy, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 889893
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.